Sunday 11 April, World Parkinson's Day
The most up-to-date results in a dossier in collaboration with our researchers
Parkinson's is a neurodegenerative disease that is more frequent among people over 60 and is therefore destined to become increasingly common due to the aging of Western societies. Even in South Tyrol, about one in every 60-year-old person suffers from it. Men are more affected, with a ratio of 2:1 to women. The disease was first described in detail at the beginning of the nineteenth century, but today there is still no cure to stop its advance. Research is focusing on the mechanisms by which the disease develops, in order to diagnose it as early as possible.
Geneticist Irene Pichler and neuroscientist Mattia Volta present the most up-to-date results in a dossier published in Eurac Research's online magazine and featuring video animation, images and an interactive timeline.
Other News & Events
13 October 2021
Il protocollo dello studio CHRIS COVID-19 a disposizione della comunità scientifica
Disponibile in modalità Open Access, rappresenta una risorsa per i ricercatori che vogliono replicare studi simili.
28 September 2021
New headquarters for the Institute for Biomedicine
From mid-2022, the Institute for Biomedicine will open its new headquarters in the NOI Techpark: the interview with our director Peter P. Pramstaller.
24 August 2021
Covid-19 in Val Gardena
Uno studio dell’Azienda Sanitaria e di Eurac Research individua diversi fattori legati alla positività a Covid-19. La ricerca si è svolta nella primavera 2020 in Val Gardena (BZ).
08 July 2021
Large genomic analysis highlights COVID-19 risk factors
A new worldwide study published in Nature reveals 13 loci that are strongly associated with infection or severe COVID-19. The Institute of Biomedicine contributed data from the CHRIS Covid 19 study ...
21 June 2021
We are Social
The Institute of Biomedicine opens its own social channel. Follow us on Twitter.
07 June 2021
Sequencing of SARS-CoV-2 variants
Our laboratories work alongside the South Tyrolean Health Authority to track and monitor variants of the SARS-CoV-2 virus.